In this short post, I propose a quick snapshot of the M&A transactions Centerview have been involved in, during 2023 and 2024, to show by the data that the biopharma acquisitions are their forte. As the WSJ reported yesterday, the shareholders of Centerview Partners are exploring the sale of a stake in the boutique bank.[…]